Radioactive seed localization in recurrent thyroid carcinoma: A case report

Radioactive seed localization in recurrent thyroid carcinoma: A case report

Introduction: Surgery is the preferred treatment for recurrent differentiated thyroid carcinoma. However, scar tissue and tissue plane distortion can significantly limit the safety and the precision of the dissection. Careful preoperative planning is key to minimizing perioperative morbidity and pos...

Full description

Bibliographic Details
Main Authors:	Michèle Beniey, Virginie Gauthier, Geneviève Coulombe, Mona El Khoury, Edgard Nassif
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	Otolaryngology Case Reports
Subjects:	Radiolocalization Radioactive seed Iodine seed Recurrence Thyroid cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468548820300114

Similar Items

Outcome of Radioactive Iodine Ablation/Treatment in Pathologically-Defined Low Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients
by: Pawana Pusuwan
Published: (2016-10-01)

Outcome of Radioactive Iodine Ablation/ Treatment in Pathologically-Defined Low Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients
by: Ajalaya Teyateeti, et al.
Published: (2016-09-01)

Success Rate of Radioactive Iodine Ablation in Low-Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients
by: Pawana Pusuwan
Published: (2016-08-01)

Success Rate of Radioactive Iodine Ablation in Low-Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients
by: Ajalaya Teyateeti, et al.
Published: (2016-07-01)

The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER
by: Tang J, et al.
Published: (2018-06-01)

To explore the curative effect of CT-guided Iodine-125 radioactive seed implantation in the treatment of stage Ⅳprimary hepatocellular carcinoma
by: Fuqiang Zhang, et al.
Published: (2021-05-01)

Lithium therapy: an unusual cause of elevated and diffuse radioactive iodine uptake.
by: Ebenezer A Nyenwe, et al.
Published: (2008-10-01)

Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer
by: Tanner Fullmer, et al.
Published: (2021-07-01)

Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy
by: Zhichao Xing, et al.
Published: (2021-01-01)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
by: Angelica Schmidt, et al.
Published: (2017-02-01)

REFRACTORY OF WELL-DIFFERENTIATED THYROID CANCER TO THE TREATMENT WITH RADIOACTIVE IODINE
by: P. O. Rumyantsev
Published: (2015-04-01)

Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council
by: P O Rumyantsev, et al.
Published: (2016-09-01)

Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
by: Xiaoran Mei, et al.
Published: (2021-05-01)

Annual Hazard Rate of Recurrence in Middle Eastern Papillary Thyroid Cancer over a Long-Term Follow-Up
by: Abdul K. Siraj, et al.
Published: (2020-12-01)

Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
by: Sun Hwa Kim, et al.
Published: (2013-03-01)

Impact of thyroiditis on 131I uptake during ablative therapy for differentiated thyroid cancer
by: Eugenie S Lim, et al.
Published: (2019-05-01)

First brachytherapy treatment of prostate cancer in Nigeria using low dose rate radioactive iodine 125
by: Oludare Folajimi Adeyemi, et al.
Published: (2020-12-01)

Radioactive Iodine Treatment and the Risk of Long-Term Cardiovascular Morbidity and Mortality in Thyroid Cancer Patients: A Nationwide Cohort Study
by: Chun-Hao Kao, et al.
Published: (2021-09-01)

Measurement of radiation doses absorbed in the thyroid cancer when treated with radioactive iodine 131I
by: Asema Mahmood Alemam
Published: (2013-06-01)

Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation
by: Jonghwa Ahn, et al.
Published: (2020-03-01)

Prevalence of Hyponatremia in Hypothyroid Patients during Radioactive I Ablation for Differentiated Thyroid Cancer: Single Institution Experience
by: Juan Carlo P. Dayrit, et al.
Published: (2016-09-01)

LENVATINIB IN TREATMENT OF RADIOACTIVE IODINE-REFRACTORY WELL-DIFFERENTIATED THYROID CARCINOMA
by: I. S. Romanov, et al.
Published: (2017-06-01)

Seeds in Chernobyl: the database on proteome response on radioactive environment
by: Katarína eKlubicová, et al.
Published: (2012-10-01)

Clinical experience in using lenvatinib in patients with progressive, radioactive iodine-refractory differentiated thyroid cancer
by: P. A. Isaev, et al.
Published: (2016-06-01)

Radioactive 131Iodine body burden and blood dose estimates in treatment for differentiated thyroid cancer by external probe counting
by: Ramamoorthy Ravichandran, et al.
Published: (2016-01-01)

Long-Term Safety and Efficacy of CT-Guided I125 Radioactive Seed Implantation as a Salvage Therapy for Recurrent Head and Neck Squamous Carcinoma: A Multicenter Retrospective Study
by: Yuliang Jiang, et al.
Published: (2021-07-01)

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer
by: Francesca Collina, et al.
Published: (2019-06-01)

Radioactive seed migration after prostate brachytherapy with Iodine-125 using loose seeds versus stranded seeds
by: Carlos A. S. Franca, et al.
Published: (2009-10-01)

Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy
by: Zin W. Myint, et al.
Published: (2015-02-01)

Is radioactive iodine- 131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
by: Marcelo Cruzick de Souza, et al.
Published: (2015-07-01)

The effect of retinoic acid in the ability of cold solid thyroid nodule to take up radioactive iodine: A preliminary study
by: Andreas Lim, et al.
Published: (2019-01-01)

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
by: Yasuko Hyogo, et al.
Published: (2018-11-01)

Clinical Treatment Efficacy of Total Thyroidectomy Combined with Radioactive Iodine on Treatment of Thyroid Cancer and Its Effect on the Quality of Life of Patients
by: Yong YANG, et al.
Published: (2019-07-01)

Thyroglobulin levels before radioactive iodine therapy and dynamic risk stratification after 1 year in patients with differentiated thyroid cancer
by: Leonardo Bandeira, et al.

Prognostic Implications of CD10 and CD15 Expression in Papillary Thyroid Carcinoma
by: Eun Ji Oh, et al.
Published: (2020-05-01)

Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
by: Jae Hoon Chung
Published: (2013-09-01)

Is postoperative radioactive iodine associated with a survival advantage among…
by: Hamed Rasha Hamdy
Published: (2017-06-01)

Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer
by: Gianoukakis AG, et al.
Published: (2016-05-01)

Management of hyperthyroidism with radioactive iodine
by: T Premprapha, et al.
Published: (2006-08-01)

Analysis of bioactive glasses obtained by sol-gel processing for radioactive implants
by: Roberto Wanderley dos Santos, et al.
Published: (2003-01-01)